Analysis of microRNA-199a-3p expression in CD4+ T cells of systemic lupus erythematosus
- PMID: 36763225
- DOI: 10.1007/s10067-023-06534-7
Analysis of microRNA-199a-3p expression in CD4+ T cells of systemic lupus erythematosus
Abstract
Objectives: Accumulating evidence have suggested microRNAs (miRNAs) play important roles in the pathogenesis of systemic lupus erythematosus (SLE). Here we aimed to explore aberrant expression of miRNAs in CD4+ T cells from SLE patients and their potential function in SLE pathogenesis.
Methods: First, next-generation sequencing was performed on CD4+ T cells from four SLE patients and three healthy controls (HCs). Candidate miRNAs were then validated in CD4+ T cells from 97 patients with SLE, 16 patients with rheumatoid arthritis, and 12 HCs using qRT-PCR. Then the relationship between the candidate miRNA and clinical characteristics was analyzed. Bioinformatics analysis and validation of the target genes of the candidate miRNA were performed.
Results: A total of 66 upregulated miRNAs and 70 downregulated miRNAs were found between SLE and normal CD4+ T cells samples. miR-199a-3p was identified significant upregulation in the CD4+ T cells of lupus patients. High expression of miR-199a-3p was correlated with several clinical characteristics including low C3 level, positive anti-dsDNA antibody, high ESR level, active lupus nephritis, and active disease activity. When distinguishing active LN from non-LN or active lupus from stable lupus, the AUCs of miR-199a-3p were 0.68 and 0.70, respectively. And the expression of miR-199a-3p, involved in JAK-STAT signaling pathway, was negatively correlated with the STAM expression in CD4+ T cells of SLE.
Conclusion: Our study suggested a novel and promising role of miR-199a-3p in CD4+ T cells for SLE. Further studies are needed to precisely determine the function of miR-199a-3p in this disease. Key Points • Aberrant expression of miRNAs in CD4+ T cells and their potential function in SLE pathogenesis remained unclear. • miR-199a-3p in CD4+ T cells plays a novel role in the pathogenesis of SLE and serves as a potential target for SLE.
Keywords: Biomarker; CD4+ T cells; JAK-STAT signaling pathway; Systemic lupus erythematosus; microRNA.
© 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
References
-
- Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365(22):2110–2121. https://doi.org/10.1056/NEJMra1100359 - DOI - PubMed
-
- Doria A, Gatto M, Zen M, Iaccarino L, Punzi L (2014) Optimizing outcome in SLE: treating-to-target and definition of treatment goals. Autoimmun Rev 13(7):770–777. https://doi.org/10.1016/j.autrev.2014.01.055 - DOI - PubMed
-
- Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC (2017) Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med 23(7):615–635. https://doi.org/10.1016/j.molmed.2017.05.006 - DOI - PubMed - PMC
-
- Morel L (2017) Immunometabolism in systemic lupus erythematosus. Nat Rev Rheumatol 13(5):280–290. https://doi.org/10.1038/nrrheum.2017.43 - DOI - PubMed
-
- Teng X, Brown J, Choi SC, Li W, Morel L (2020) Metabolic determinants of lupus pathogenesis. Immunol Rev 295(1):167–186. https://doi.org/10.1111/imr.12847 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials